MLKL and melanoma: The CV extract has been also reported to induce RIPK1/RIPK3/MLKL-mediated necroptosis in non-pigmented melanoma cells and depigmented (with suppressed melanogenesis) melanoma cells, since co-treatment of the cells with necroptosis inhibitors abrogated the CV-induced cell death [126,127].